Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.

Rheumatology (Oxford) 2017 07;56(7):1102-1110

Clinical Research, Unit, Dudley Group NHS Foundation Trust, West Midlands, UK.

Objectives: Cardiovascular disease (CVD) risk calculators developed for the general population do not accurately predict CVD events in patients with RA. We sought to externally validate risk calculators recommended for use in patients with RA including the EULAR 1.5 multiplier, the Expanded Cardiovascular Risk Prediction Score for RA (ERS-RA) and QRISK2.

Methods: Seven RA cohorts from UK, Norway, Netherlands, USA, South Africa, Canada and Mexico were combined. Data on baseline CVD risk factors, RA characteristics and CVD outcomes (including myocardial infarction, ischaemic stroke and cardiovascular death) were collected using standardized definitions. Performance of QRISK2, EULAR multiplier and ERS-RA was compared with other risk calculators [American College of Cardiology/American Heart Association (ACC/AHA), Framingham Adult Treatment Panel III Framingham risk score-Adult Treatment Panel (FRS-ATP) and Reynolds Risk Score] using c-statistics and net reclassification index.

Results: Among 1796 RA patients without prior CVD [mean ( s . d .) age: 54.0 (14.0) years, 74% female], 100 developed CVD events during a mean follow-up of 6.9 years (12430 person-years). Estimated CVD risk by ERS-RA [mean ( s . d .) 8.8% (9.8%)] was comparable to FRS-ATP [mean ( s . d .) 9.1% (8.3%)] and Reynolds [mean ( s . d .) 9.2% (12.2%)], but lower than ACC/AHA [mean ( s . d .) 9.8% (12.1%)]. QRISK2 substantially overestimated risk [mean ( s . d .) 15.5% (13.9%)]. Discrimination was not improved for ERS-RA (c-statistic = 0.69), QRISK2 or EULAR multiplier applied to ACC/AHA compared with ACC/AHA (c-statistic = 0.72 for all) or for FRS-ATP (c-statistic = 0.75). The net reclassification index for ERS-RA was low (-0.8% vs ACC/AHA and 2.3% vs FRS-ATP).

Conclusion: The QRISK2, EULAR multiplier and ERS-RA algorithms did not predict CVD risk more accurately in patients with RA than CVD risk calculators developed for the general population.

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850220PMC
July 2017
36 Reads

Publication Analysis

Top Keywords

cvd risk
20
risk calculators
16
eular multiplier
16
risk
13
qrisk2 eular
12
cvd
9
predict cvd
8
treatment panel
8
net reclassification
8
multiplier ers-ra
8
cvd events
8
risk scores
8
calculators developed
8
cardiovascular risk
8
general population
8
developed general
8
ers-ra
6
[mean
6
patients
5
acc/aha
5

Altmetric Statistics

References

(Supplied by CrossRef)
The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation
Bruce et al.
J Rheumatol 2003

Similar Publications